CytomX Therapeutics
Price & Volume
Stats
See more52W Range | $2.43-$8.21 |
Market Cap | $538.2M |
Shares Short | 38M |
Financials
See moreRevenue (12 Mos) | $18.3M |
Revenue Growth (YoY) | -92.4% |
Gross Profit (12 Mos) | $18.3M |
Diluted EPS | -$0.51 |
News
See moreYahoo Finance • 2 months ago
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update
Yahoo Finance • 4 months ago
CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
Yahoo Finance • 5 months ago
Russell 3000 Shuffle: Ocugen, Nektar slated to join among healthcare stocks; Nano-X to drop off
Yahoo Finance • 5 months ago
CytomX Therapeutics to Present at Upcoming June Investor Conferences
About
CEO | Dr. Sean A. McCarthy DPHIL |
CFO | Mr. Christopher W. Ogden |
Address | 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 69 |